To include your compound in the COVID-19 Resource Center, submit it here.

Victoza liraglutide: Phase IIIa started

Novo Nordisk disclosed in its 1H11 earnings that in June it began a double-blind, placebo-controlled international Phase IIIa

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE